Virtus ETF Advisers LLC Catalyst Biosciences, Inc. Transaction History

Virtus ETF Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 05, 2019	SELL	$6.59 - $11.28 $118,073 - $202,103	-17,917 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$9.35 - $12.44 $122,896 - $163,511	-13,144 Reduced 42.32%	17,917 $193,000
Q2 2018 Aug 10, 2018	BUY	$9.11 - $28.88 $282,965 - $897,041	31,061 New	31,061 $362,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.